View More Recent Stories
-
Citi Isues 1Q10 Earnings Preview on Generic Pharmaceuticals -Outperformance Expected
-
Citi Reiterates a 'Buy' on Mylan Inc (MYL); Thoughts on Recall of Acino’s European Generic Plavix
-
Notable Analyst Rating Changes 1/8: HAL, AMAT, JCP, AGU, ESV, RDN, More Upgraded; M, KO, STX, ERIC, WEN, PCS, More Downgraded
-
Active equity option families in first 30 minutes of trading according to Track Data are: C GE MYL BAC
-
David Moenning's Daily State of the Markets: 5/14
-
David Moenning's Daily State of the Markets: 4/30
-
Citi Reiterates a 'Buy' Rating on Teva Pharmaceutical (TEVA)
-
David Moenning's Daily State of the Markets: 3/13
-
David Moenning's Daily State of the Markets 2/23
-
Notable Analyst Rating Changes 1/21: F, UL, RYAAY, JBL Upgraded; WMT, AA, WFR, FRX Downgraded
-
Citi Initiates Coverage on Mylan (MYL) with a Buy
-
David Moenning's Daily State of the Markets: 1/07
-
David Moenning's Daily State of the Markets: 8/06
-
David Moenning's Daily State of the Markets: 6/27
-
David Moenning's Daily State of the Markets: 5/8
-
Citi Upgrades Mylan (MYL) to Buy
-
David Moenning's Daily State of the Markets: 2/7

